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Abstract
Breast conserving surgery (BCS) for
breast cancer aims for optimal onco-
logical results with minimal tissue
excision. Positive margins due to
insufficient resection results in sig-
nificant numbers of patients requir-
ing re-excision, which could be resolved with intra-operative margin analysis
(IMA). High wavenumber (HWN) Raman Spectroscopy (RS) examines the differ-
ence in protein/lipid environment and water content in tissues. Fluorescence
from haemoglobin and blue dye surgical pigments (commonly present in excised
breast tissue) can confound HWN RS. We present a Raman system with 785 nm
excitation laser and indium gallium arsenide camera capable of quantifying
changes in water content in different environments (protein-rich and lipid-rich)
by measuring the water/total area ratio (W/TAR) of the HWN spectrum. We
demonstrate that haemoglobin and blue dye do not adversely affect water con-
tent analysis by the W/TAR calculation. Measurement of paired tumour/non-
tumour human breast tissue specimens showed the biochemical differences
between tissues, and spectral analysis with W/TAR demonstrated large differ-
ences in water content and that our Raman system can accurately differentiate
between tumour and non-tumour tissue, even in the presence of surgical pig-
ments. This provides proof of principle that this Raman system is suitable for fur-
ther investigation with a view to providing IMA in the clinical environment.
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1 | INTRODUCTION
The aim of breast conserving surgery (BCS) in the treat-
ment of breast cancer is to give optimal oncological
result, with minimal excess tissue excision to maintain
satisfactory cosmetic outcome. If there is residual tumour
at the resected edge (positive margins) of the excised
specimen, further resection is advised to reduce recur-
rence risk [1, 2]. This occurs in 17% of BCS in the UK [3],
causing significant financial burden for the health service
and patient anxiety [4]. There are currently no univer-
sally accepted methods of performing intra-operative
margin analysis (IMA) in BCS.
Raman spectroscopy (RS) has shown excellent diag-
nostic capabilities in a number of cancers [5–7], with a
sensitivity of 94% and specificity of 96% in diagnosing
breast cancer [8]. A limitation is the time taken for spec-
tral analysis with small sampling volumes which make it
difficult to provide IMA in relevant time frames. The
majority of Raman studies use the “fingerprint” spectral
region of 800 to 1800 cm−1 due to its molecular specificity
[7]; however, the high wavenumber (HWN) region of
2800 to 3800 cm−1 is capable of comparable diagnostic
accuracy with simpler instrumentation [9], particularly
when discriminating between significantly different path-
ological states [10–12]. The HWN region is sensitive to
changes in protein, lipid and water, and the increased
spectral intensity and less complex spectral analysis can
reduce the time taken for signal acquisition [10].
The sensitivity of the HWN region to water is of inter-
est, as tumours have a higher water concentration than
surrounding normal tissue [13]. Garcia-Flores et al dem-
onstrated with HWN RS that breast tumours in rat
models had higher protein and water signals, and normal
(adipose) tissue had a higher lipid and low water signals
[14], which was confirmed in human breast tissue using
HWN RS [15]. Barroso et al demonstrated the diagnostic
ability of water content differences in oral squamous cell
carcinoma with HWN RS [16]. A recent study used part
of the HWN region to screen for areas of potential
tumour in breast tissue [17]. These works suggest that
HWN RS could be used for IMA in BCS but no studies to
date have systematically explored this.
A clinical limitation of optical techniques is the pres-
ence of fluorescent surgical pigments [18]. Fluorescence
occurs when the incident light excites fluorophores pro-
ducing a strong broadband signal that overwhelms the
weaker Raman signal, thus obliterating detection of
Raman scattering. Two potentially fluorescent pigments
are commonly found during BCS; haemoglobin (from
human blood), and Patent Blue Dye (“BD”) (injected into
breast tissue for localization of sentinel lymph nodes).
Lymph node localization using BD occurs in 23% to 54%
of breast cancer operations [19]. In previous studies, sam-
ples with surgical pigments have either not been included
[17], been washed [16] or the stained areas have been
purposefully avoided [20] which limits their clinical
application.
Our preliminary HWN RS experiments using a low
wavelength (680 nm) excitation laser and CCD (a com-
monly used configuration [10, 16, 17]) demonstrated high
background fluorescence, and complete obscuration of
the Raman signal within the shot noise contribution from
the considerable BD fluorescence. A laser with a longer,
less energetic wavelength (785 nm) combined with an
indium gallium arsenide (InGaAs) camera, more sensi-
tive to the longer near infrared wavelengths, allows the
HWN region to be measured with a reduced fluorescence
background from biological tissue, while maintaining
good signal-to-noise [21], which has been demonstrated
in circumventing fluorescence in melanoma diagno-
sis [22].
The aim of this study was to identify an HWN Raman
system able to differentiate between tumour and non-
tumour human breast tissue specimens based on differ-
ences in water content and assess the diagnostic ability in
the presence of surgical pigments, with a view to
future IMA.
2 | METHODS
2.1 | Specimens for measurement
2.1.1 | Phantom construction
Gelatine phantoms were constructed by mixing porcine
skin gelatine powder (Sigma Aldrich, Germany) with dis-
tilled water (total weight 10 g) to produce final concentra-
tions of 85% to 95% water [23] (representative of protein-
rich tissue with a high water content, to mimic tumour
conditions).
BD gelatine phantoms were 90% water gelatine
phantoms with Patent Blue V sodium salt (Sigma
Aldrich) dissolved in the water at a 1% dye concentra-
tion (the concentration often injected into the breast).
The dye was added at the mixing stage to the solution
to produce a final phantom concentration of 0.01% or
0.1% BD, to mimic the concentration once the dye has
diffused into the breast tissue and undergone handling.
The solutions were stirred in a 55C water bath until
dissolved (20-30 minutes) then poured into 2.5 cm3
moulds.
Soya bean oil phantoms were used as a lipid phantom
(protocol adapted from Merritt et al[24]). Organic soya
bean oil (Clearspring, UK) was mixed with a 4% lipid
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volume of Triton X-100 (Sigma-Aldrich, Germany) for
emulsification. The warmed solution was stirred for
5 minutes in a 55C water bath before distilled water was
added to produce a 10 mL total volume at the desired
water concentration (range 40%-95% water, to mimic the
physiologically normal range [25]). The solution was
stirred for 5 minutes and underwent sonification with a
Hielscher Ultrasonics UP100H Handheld ultrasonic pro-
cessor (Hielscher Ultrasonics, Teltow, Germany) at
30 kHz with 100% amplitude and 100% pulse for
5 × 10 second pulses to create a liquid emulsion.
Phantoms were covered and stored at 5C for
24 hours until Raman measurements were taken at room
temperature.
2.1.2 | Pork meat phantoms
Pork chops with clearly demarked protein and lipid-rich
sections (Tesco, UK) were used as a biological environ-
ment previously used to mimic human breast tissue [26].
Two pieces of pork meat (3 cm3) were dissected. One was
stained with 1% solution of Patent BD until it was visu-
ally as “blue” as excised breast tissue (judged by a sur-
geon). One was stained with a 7.5% solution of bovine
haemoglobin (Sigma Aldrich) in distilled water: the esti-
mated haemoglobin concentration in a breast specimen
after excision and handling.
2.1.3 | Breast specimens
Human breast tissue samples were obtained from the
Royal Devon and Exeter Hospital Tissue Bank as part of
lumpectomy or mastectomy operations taken with
informed consent during the patients' standard oncological
treatment, having been approved by the local NIHR Exeter
Clinical Research Facility (CRF) Tissue Bank, (CRF320;
Tissue bank ethics number 16/SC/0162). Patients were
females aged ≥18 years, able to consent, with a malignant
tumour of ≥2 cm. The specimen was excised, sliced and a
2 to 5 mm3 biopsy taken from the tumour, and a separate
one from normal tissue, by a trained pathology practi-
tioner. The research biopsies were snap-frozen in liquid
nitrogen and stored at −80C in the NIHR Exeter CRF Tis-
sue Bank before being transferred to and frozen-sectioned
at Gloucestershire Hospitals Pathology Department. An
H&E section underwent routine histopathological analy-
sis. The pathology classification and routine demographic
data collected from patient notes were pseudonymously
linked to the research specimens by the Tissue Bank. Bulk
specimens were thawed at room temperature immediately
prior to Raman measurements.
2.2 | Raman equipment configuration
Raman spectra were acquired for all experiments with a
previously described fibre optic probe [27]. It is a stan-
dard stainless steel 23 gauge thin wall needle within
which is a bundle of seven low-OH silica optical fibres
stripped of their buffer (105 μm core, 0.22NA, Thorlabs)
arranged as six collection fibres around one excitation
fibre, giving an area of collection of 5.19 × 104 μm2. Sam-
pling volume modelled (not published) using phantoms
was established to be of the order of 1 mm3. Excitation
light at a wavelength of 785 nm was provided by an IPS
spectrum stabilized laser module (Innovative Photonic
Solutions) through a 785 nm laser clean up filter
(Thorlabs, NJ). Raman scattered light passed through an
830 nm long-pass edge filter (Semrock, Rochester) from
the needle tip. The system provided a maximum power of
250 mW at 785 nm at the tip. The scattered light was pas-
sed through the same specification fibre to the entry port
on a Kaiser Holospec Imaging Spectrograph (Kaiser Opti-
cal Systems Inc., Ann Arbour, Michigan) with a high
throughput, broadband, transmissive holographic grat-
ing, HVG 800 (Kaiser) and coupled to an InGaAs line
scan camera (iDus InGaAs 1.7 μm, Andor, Belfast, UK),
thermoelectrically cooled to −70C.
Spectra were calibrated daily using the spectral peaks
of paracetamol, ethanol and acetylnitrile. A daily mea-
surement with no laser or background light was taken for
dark noise subtraction.
Measurements were obtained with the probe in light
contact with the specimen and spectra were acquired for
5 seconds with five accumulations over the surface of the
phantoms (n = 3 or 5) or breast specimen (n = 5-8). Mea-
surements were obtained at random intervals over the
largest surface of the specimen to ensure adequate repre-
sentative sampling of tissue—the number of measure-
ments taken depended on the surface area of the
specimen and took less than 10 minutes to complete.
2.3 | Data processing analysis
Spectra were recorded using SOLIS software (Andor) and
processed in MATLAB (MathWorks). The mean of the
accumulations was taken, and a smoothed dark noise
spectrum was subtracted (smoothing obtained by a Sav-
itzky-Golay filter with a seventh order polynomial of the
noise reading). The HWN region spectra underwent fluo-
rescence baseline subtraction using a linear fit for the
phantom spectra. A subtraction of a third order polyno-
mial fit (previously used for HWN baseline subtraction in
biological tissue [28, 29]) was applied to breast tissue
spectra due to increased autofluorescence. For
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visualization purposes only, spectra presented were nor-
malized to the CH stretch of protein/lipid at 2940 cm−1.
The analysed spectra were not normalized. As a measure
of water content, and to quantify changes within the
HWN spectrum, the water/total area ratio was calculated,
as described by Masson et al [29]. For each spectrum, the
area under the curve (AUC) of the water peak (which
also contains some contribution from the NH peak at
3280 cm−1) between 3035 and 3680 cm−1, and the AUC
of the total HWN region between 2850 and 3680 cm−1
was calculated, then the AUC water peak was divided by
AUC of the total HWN region to give the W/TAR. Spec-
tra were analysed with this method, as it captures the
entire water peak hence changes can be detected in both
bound and unbound water [30], and the technique has
been previously validated to detect water content changes
in lipid rich and fluorescent tissues [29]. The mean
W/TAR ratio and SD (SD) is used to describe each speci-
men. For scatter graphs, a linear fit was calculated based
on all points with quality of fit described by the root
mean square error.
Statistical analysis to compare W/TAR between speci-
mens was performed by two-sided student t test or one-
way analysis of variance (ANOVA) depending on number
of groups and statistical significance P < .05.
3 | RESULTS
3.1 | Quantification of change in water
content
Figure 1 presents the results in two different environ-
ments, Figure 1A shows a protein/water environment
(gelatine phantoms) and Figure 1B shows a lipid/water
environment (soya bean oil phantom).
In both environments, there is a change in the
HWN spectra with a change in the water content.
There was a relative decrease in the OH stretch
region (3035-3680 cm−1) when normalized to the CH
stretch region (2850-3035 cm−1) (as measured by a
decrease in W/TAR), with a decrease in water
FIGURE 1 Demonstrating the ability of the Raman system to measure and quantify changes in water concentration in two different
environments: A, Mean Raman spectra normalized to peak at 2940 cm−1 of each gelatine phantom with shading either side in the same
colour ±1 SD. B, Mean water/total area ratio (W/TAR) of each gelatine phantom (not normalized), error bars ±1 SD Red line is line of best
fit (gradient = 0.57, root mean square error [RMSE] 0.0009). C, Mean Raman spectra normalized to peak at 2940 cm−1 of each soya bean oil
phantom with shading either side in the same colour ±1 SD. D, Mean W/TAR (not normalized) of each soya bean oil phantom, error bars
±1 SD (gradient = 1.26, RMSE = 0.02). In all graphs, mean represents a mean of n = 5 measurements taken from different points of each
specimen
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content. There was a linear relationship between
W/TAR and known water content in the phantoms—
the gradient for gelatine phantom W/TAR was 0.57,
and the gradient for soya bean oil phantom W/TAR
was 1.26.
3.2 | Overcoming fluorescence of
surgical pigments
Figure 2 demonstrates that, in the presence of
haemoglobin and BD pigment, HWN Raman signal was
unaffected with no significant difference in the mean
W/TAR between specimens (untreated pork 0.82
[SD 0.08]; haemoglobin treated pork 0.81 [SD 0.06]; BD
treated pork 0.85 [SD 0.02]; P = .49 one-way ANOVA).
Due to particular concerns for BD fluorescence, mea-
surements were performed in BD spiked gelatine phan-
toms that had concentrations expected in excised breast
tissue. There was a slight trend towards increased mean
W/TAR in the presence of BD (no BD W/TAR = 0.92 [SD
0.007], 0.01% BD W/TAR = 0.93, [SD 0.008], 0.1% BD W/
TAR = 0.93, [SD 0.003]), but this was not significantly
different (P = .28; one-way ANOVA). The maximum
range of change in individual W/TAR was 3% (range
0.91-0.94) which, based on the gradient of gelatine phan-
toms in Figure 1, is equivalent to only a 5% difference in
water content.
3.3 | Differentiating between tumour
and non-tumour human breast tissue
Paired samples from nine patients (tumour samples
n = 9, non-tumour samples n = 9) were measured. All
patients were female, mean age 65 (range 41-84), three
were pre-menopausal and six post-menopausal. Five
underwent a lumpectomy and four mastectomy for inva-
sive breast carcinoma with a mean tumour size of 30 mm
(range 19-51 mm). Six had invasive ductal carcinoma,
two lobular carcinoma and one mixed carcinoma. All
tumours were oestrogen receptor positive, with one also
FIGURE 2 Graphs showing the effect of surgical pigments on the mean water/total area ratio (W/TAR) for High wavenumber (HWN)
Raman spectra. A, Bar chart showing mean W/TAR in different treatments of pork specimens; untreated—no pigment, Hb—pork treated
with haemoglobin pigment, BD—pork treated with patent blue dye pigment. B, Bar chart showing mean W/TAR in different concentrations
of Blue Dye (BD) in 90% water gelatine phantoms. Data are not normalized; Error bars ±1 SD
FIGURE 3 Photos of breast tissue included in the study, with different pigments. A, Breast biopsy tissue with minimal additional
pigments (though a small amount of haemoglobin still present). B, Breast biopsy tissue obviously stained with haemoglobin pigment. C,
Breast biopsy tissue stained with BD
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HER2 positive and eight had associated ductal carcinoma
in situ. Eight had a sentinel lymph node biopsy, and one
an axillary node clearance, with four having axillary
lymph node metastatic deposits.
All specimens had some natural haemoglobin pig-
ment visible, and in four BD was seen (Figure 3).
All specimens (n = 18) were measured to obtain a
total of 116 spectra. The mean spectrum from all tumour
specimens (n = 9) and all non-tumour specimens (n = 9)
show clear spectral difference between the specimen
types (Figure 4A). Tumour specimens have a narrow
peak at 2900 to 2950 cm−1 from the CH2 asymmetric
stretch, and a peak in the OH stretch region between
3050 and 3680 cm-1 [31] suggesting tumour tissue has a
high protein content and high water content. Non-
tumour specimens have a broader peak at 2855 to
2950 cm−1 CH3 stretch region, consistent with lipid [31],
and minimal signal in the OH stretch region—suggesting
predominantly fatty tissue with a low water content.
The W/TAR was calculated for each spectrum, and
the mean W/TAR of spectra from tumour tissue speci-
mens (mean W/TAR = 0.7559; SD 0.1022) was signifi-
cantly higher than non-tumour tissue (mean W/
TAR = 0.1587; SD 0.1339) (P = 7 × 10−6; t test)
(Figure 4B). Using a W/TAR cut off of 0.5 for diagnosis,
for example, samples with W/TAR <0.5 were classified as
non-tumour, and samples with W/TAR ≥0.5 were classi-
fied as tumour, all samples were correctly classified,
suggesting W/TAR analysis can accurately differentiate
between tumour and non-tumour tissue.
To assess the diagnostic performance in the presence of
BD, samples were grouped and W/TAR was analysed
according to tumour or non-tumour classification, and
whether there was BD present (with BD) or not (no BD) (Fig-
ure 5). One-way ANOVA of all groups was significantly
different (P = .00005); multi-technique comparison showed
that tumour, with BD (n = 4; mean W/TAR = 0.7415; SD
0.0795) was similar to tumour, no BD (n = 5; mean W/
TAR = 0.7675; SD 0.1255) (P = .5048); and non-tumour, with
BD (n = 4; mean W/TAR 0.0957; SD 0.0639) was similar to
non-tumour, no BD (n = 5; mean W/TAR 0.2091; SD 0.1602)
(P = .987). Comparison between the mean W/TAR tumour
(both BD and no BD) compared to non-tumour, both BD
and no BD, showed statistical significance (P < .001). The
presence of BD did not significantly alter the Raman signal
between the same tissue types, and W/TAR can differentiate
between tumour and non-tumour tissue in the presence
of BD.
FIGURE 4 High wavenumber (HWN) Raman differentiating between tumour and non-tumour human breast tissue. A, Raman
spectrum of tumour (n = 9) (red) and non-tumour (n = 9) (green) human breast tissue, normalized to peak at 2940 cm−1. Central spectrum
is mean spectrum with outlying lines and shading either side in the same colour ±1 SD. B, Bar Graph of mean water/total area ratio
(W/TAR) according to sample type; data not normalized; error bars ±1 SD * denotes significant difference in comparison of the means;
P = 7 × 10−6; t test
FIGURE 5 Bar chart showing the mean water/total area ratio
(W/TAR) for human breast tissue specimens according to specimen type,
and whether there was blue dye present (BD) or not (no BD). Data not
normalized. † denotes comparison between tumour specimens W/TAR,
P > .05, and ‡ denotes comparison between non-tumour specimens W/
TAR, P > .05. WhenW/TAR of either group of †was compared to either
group of ‡, it reached statistical significance P < .001; denoted by *
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4 | DISCUSSION
This study demonstrates a Raman system that can quantify
changes in water content in different micro-environments
(protein-rich and lipid-rich) and can perform accurate
HWN RS tissue diagnosis in the presence of haemoglobin
and BD. We have demonstrated a method of spectral analy-
sis (W/TAR) that can assess the difference in water content
of human breast specimens and demonstrates a significant
difference between tumour and non-tumour tissue; using a
cut-off of 0.5, the W/TAR can accurately differentiate
between tumour and non-tumour breast tissue.
The HWN spectra in protein-rich and lipid-rich
micro-environments demonstrates that water content
changes can be detected by HWN RS, and quantified by
calculation of the W/TAR. The relationship between
W/TAR and specimen water content is dependent on the
waters' microenvironment: in a 90% water protein-rich
phantom the W/TAR was 0.92, whereas in a 90% water
lipid-rich phantom the W/TAR was 0.82. The rate of
change of W/TAR is also dependent on water microenvi-
ronment—exemplified by the different linear fit gradi-
ents. This demonstrates that quantification of water
content using HWN RS is dependent on the microenvi-
ronment of the water. Biological tissues have areas of dif-
ferent protein and lipid ratios so quantification of
changes in water content requires detailed scrutiny of the
CH region and quantification of protein-to-lipid ratio.
Therefore, absolute W/TAR cannot be used as a standard
measure of water quantification across tissue types, but
these results show that it can demonstrate differences in
water concentration in the different environments found
in breast tissues.
Previous work demonstrating the differences in the
HWN spectra of tumour and non-tumour breast tissue,
have been limited to rat models [14], the laboratory envi-
ronment [15] or have not captured the water peak [17].
This study demonstrates, with clinical specimens, that
breast tumours are protein and water rich environments,
and non-tumour breast tissues are lipid-rich, with a low
water content and the simple analysis of W/TAR can
analyse tissue based on water content. By using a laser
with a longer wavelength combined with an InGaAs
camera, we have avoided inducing fluorescence from sur-
gical pigments and demonstrated that the diagnostic abil-
ity was unaffected by the presence of BD.
There are some limitations to this study. Frozen sam-
ples may have a different “true” water content compared to
fresh tissue. However, the samples were immediately snap-
frozen on collection and measured rapidly on thawing,
reducing dehydration time which minimizes differences in
water content from fresh samples. Biopsy samples were
small compared to larger breast specimens measured in
IMA; however, one would expect more rapid dehydration
from smaller samples (with increased surface area), and so
the differences observed between tissue types may be an
underestimate. The probe sampling volume is not suitable
for analysing a large specimen in a timely manner for
IMA. However, now the proof of principle to obtain diag-
nostic HWN Raman signals has been achieved the probe
can be optimized to analyse the larger tissue volumes
needed for IMA. Other work in the group has demon-
strated the ability of deep Raman techniques to probe bur-
ied regions of high water content within large volumes of
biological tissues [26]. This study was performed in a small
number of samples; however, they have paired control
samples allowing for robust analysis of the diagnostic abil-
ity of W/TAR to differentiate between tissue types in an
individual. These findings should be validated in future
studies, by testing the cut-off threshold on a larger data set
of freshly excised samples (non-frozen).
5 | CONCLUSIONS
We present an HWN Raman system capable of signal
acquisition in the presence of the surgical pigments of
haemoglobin and patent BD, and quantifying changes in
water content. We demonstrate in human breast tissue,
for the first time, the ability to differentiate between
tumour and non-tumour tissue based on water content in
the presence of surgical pigments of haemoglobin and
patent BD with HWN RS. This approach warrants further
investigation with a view to providing future IMA in the
clinical environment.
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